MHRA and international partners publish five guiding principles for machine learning-enabled medical devices
The Medicines and Healthcare products Regulatory Agency, US Food and Drug Administration and Health Canada have collaborated to identify five guiding principles for the development of predetermined change control plans (PCCPs). These guiding principles for PCCPs aim to remove the regulatory burden for developers of machine-learning-enabled medical devices, enabling reallocation of resources to improve product performance for patients.
Read the news story from Medicines and Healthcare products Regulatory Agency published on 24 October 2023.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (12 février 2024). MHRA and international partners publish five guiding principles for machine learning-enabled medical devices. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/vtbs





